12 2 STA T . 2 59 5 PUBLIC LA W 11 0– 2 7 5 —J UL Y 15 , 200 8‘ ‘ (3)arepo r t o nsuch e v a l uat i on not later than J anuar y1,20 11 .’ ’. SEC.304 . IOMR E P OR T SO NB EST PR A CTICES F OR CON DU CTIN G S Y STEMATIC RE V IE W SOFC L INICAL EFFECTIVENESS RESEARC H AND FOR DEVELOPING CLINICAL PROTOCOLS. (a) SYSTEMA T ICR E V IE W S OFCL I N ICAL E FFECTIVENESS RESEA R C H . — (1) ST UD Y.— N ot later than 6 0 d ays a f ter the date of the enact m ent of this A ct, the Secretary of H ealth and Human Services shall enter into a contract w ith the I nstitute of M edi - cine of the National Academies (in this section referred to as the ‘‘Institute’’) under which the Institute shall conduct a study to identify the methodolo g ical standards for conducting systematic reviews of clinical effectiveness research on health and health care in order to ensure that organi z ations conducting such reviews have information on methods that are o bj ective, scientifically valid, and consistent. (2) RE P ORT.—Not later than 1 8 months after the effective date of the contract under paragraph (1), the Institute, as part of such contract, shall submit to the Secretary of Health and Human Services and the appropriate committees of juris- diction of Congress a report containing the results of the study conducted under paragraph (1), together with recommendations for such legislation and administrative action as the Institute determines appropriate. (3) P ARTICIPATION.— T he contract under paragraph (1) shall re q uire that sta k eholders with e x pertise in conducting clinical effectiveness research participate on the panel responsible for conducting the study under paragraph (1) and preparing the report under paragraph (2). (b) CLINICAL PROTOCOLS.— (1) STUDY.—Not later than 60 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall enter into a contract with the Institute of Medi- cine of the National Academies (in this section referred to as the ‘‘Institute’’) under which the Institute shall conduct a study on the best methods used in developing clinical practice guidelines in order to ensure that organizations developing such guidelines have information on approaches that are objec- tive, scientifically valid, and consistent. (2) REPORT.—Not later than 18 months after the effective date of the contract under paragraph (1), the Institute, as part of such contract, shall submit to the Secretary of Health and Human Services and the appropriate committees of juris- diction of Congress a report containing the results of the study conducted under paragraph (1), together with recommendations for such legislation and administrative action as the Institute determines appropriate. (3) PARTICIPATION.—The contract under paragraph (1) shall require that stakeholders with expertise in making clinical recommendations participate on the panel responsible for con- ducting the study under paragraph (1) and preparing the report under paragraph (2). Contrac t s. Contracts. De a dli ne.
�
